Home Compare BMRN vs IOT
Stock Comparison · Single-driver result

BioMarin Pharmaceutical vs Samsara: Which Stock Looks Stronger in 2026?

The structural profiles are close, with BioMarin Pharmaceutical carrying a narrow edge on growth. Samsara still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves through growth, where Samsara Inc. holds the stronger read even though the broader score still favours BioMarin Pharmaceutical Inc..

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #7
within BioMarin Pharmaceutical Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

Most of the shared profile comes through investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMRN
BioMarin Pharmaceutical Inc.
47
Peer-Score
Signal qualityHigh
vs
IOT
Samsara Inc.
46
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: BMRN vs IOT Profitability 48 11 Stability 42 44 Valuation 56 52 Growth 36 90 BMRN IOT
Gap Ranking
#1 Growth +54
#2 Profitability +37
#3 Valuation +4
#4 Stability +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMRN and IOT Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMRNIOT Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Relative Position vs Comparable Companies
Growth
Samsara Inc. ranks near the top of the group on growth; BioMarin Pharmaceutical Inc. sits in the weaker half.
Profitability
BioMarin Pharmaceutical Inc. sits higher in the group on profitability, adding to the overall structural advantage.
Growth — Dominant Gap
BMRN
36
IOT
90
Gap+54in favour of IOT

The clearest distance comes from a stronger growth profile.

What else supports the lead

Profitability adds some additional support to the lead, with a 20.5-point operating margin advantage.

What this means for the comparison

Growth points one way, even though the overall score still points the other way.

Explore full peer positioning in AssetNext

Break down the BMRN vs IOT comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BMRN and IOT each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.